The most common activating genetic alterations in melanoma include v-Raf murine sarcoma viral oncogene homolog B (BRAF) (~50%), RAS viral oncogene homolog (RAS) (~25%) and Neurofibromin 1 (NF1) (~15%) mutations. This evidence concerns the gene BRAF and melanoma.